The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-hydroxy-5-((4-hydroxypiperidin-1-yl)sulfonyl)-N-(3,4,5-trifluorophenyl)benzamide ID: ALA4557194
PubChem CID: 155554574
Max Phase: Preclinical
Molecular Formula: C18H17F3N2O5S
Molecular Weight: 430.40
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1cc(F)c(F)c(F)c1)c1cc(S(=O)(=O)N2CCC(O)CC2)ccc1O
Standard InChI: InChI=1S/C18H17F3N2O5S/c19-14-7-10(8-15(20)17(14)21)22-18(26)13-9-12(1-2-16(13)25)29(27,28)23-5-3-11(24)4-6-23/h1-2,7-9,11,24-25H,3-6H2,(H,22,26)
Standard InChI Key: LEAWGGDJFLXVLQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
6.7563 -14.8663 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9350 -14.8663 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.3436 -15.5781 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2278 -12.8109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2266 -13.6345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9388 -14.0476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6526 -13.6341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6498 -12.8073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9370 -12.4020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3601 -12.3960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0734 -12.8019 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3570 -11.5747 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7796 -12.3907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4914 -12.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2012 -12.3894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1986 -11.5672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4802 -11.1574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7733 -11.5744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4742 -10.3361 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.9083 -11.1509 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.9144 -12.7957 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.2267 -15.2774 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5183 -14.8663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8085 -15.2712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8041 -16.0929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5157 -16.5080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2317 -16.0973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0906 -16.5028 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9346 -11.5807 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 11 1 0
10 12 2 0
11 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
17 19 1 0
16 20 1 0
15 21 1 0
6 2 1 0
2 22 1 0
22 23 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
25 28 1 0
9 29 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 430.40Molecular Weight (Monoisotopic): 430.0810AlogP: 2.21#Rotatable Bonds: 4Polar Surface Area: 106.94Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.77CX Basic pKa: ┄CX LogP: 1.56CX LogD: 0.85Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.65Np Likeness Score: -1.67
References 1. Na HG, Imran A, Kim K, Han HS, Lee YJ, Kim MJ, Yun CS, Jung YS, Lee JY, Han SB.. (2020) Discovery of a New Sulfonamide Hepatitis B Capsid Assembly Modulator., 11 (2): [PMID:32071684 ] [10.1021/acsmedchemlett.9b00550 ]